The Effect of Laser Diode MicroPulse Laser in Patients with Acute Central Serous Retinopathy in Comparison with Control Group: A Clinical Trial Study

The aim of this study was to determine the effectiveness of diode MicroPulse laser for improving visual acuity in patients with acute central serous retinopathy. In this clinical trial study, 26 patients with acute central serous retinopathy were selected and divided into two groups of 13; the first group was treated with diode MicroPulse laser; and in the second group, no intervention was performed. Patients in both groups were followed for three months, and visual acuity and recovery were compared between the two groups. The visual acuity (logMAR) before the start of treatment and at the 4th and 12th week of treatment did not show a significant difference between the two groups. In intragroup examination, visual acuity (logMAR) in both groups was significantly different (P < 0.01), but there was no significant difference between the two groups in the intergroup analysis (P = 0.82). Although the results of this study indicate that diode MicroPulse laser improves clinical and anatomical results in patients with acute central serous retinopathy, there is no statistically significant difference compared with spontaneous improvement of these patients.